Correlation Between Affiliated Resources and CytoMed Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Affiliated Resources and CytoMed Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Affiliated Resources and CytoMed Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Affiliated Resources Corp and CytoMed Therapeutics Limited, you can compare the effects of market volatilities on Affiliated Resources and CytoMed Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Affiliated Resources with a short position of CytoMed Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Affiliated Resources and CytoMed Therapeutics.

Diversification Opportunities for Affiliated Resources and CytoMed Therapeutics

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between Affiliated and CytoMed is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Affiliated Resources Corp and CytoMed Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytoMed Therapeutics and Affiliated Resources is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Affiliated Resources Corp are associated (or correlated) with CytoMed Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytoMed Therapeutics has no effect on the direction of Affiliated Resources i.e., Affiliated Resources and CytoMed Therapeutics go up and down completely randomly.

Pair Corralation between Affiliated Resources and CytoMed Therapeutics

Given the investment horizon of 90 days Affiliated Resources Corp is expected to generate 2.29 times more return on investment than CytoMed Therapeutics. However, Affiliated Resources is 2.29 times more volatile than CytoMed Therapeutics Limited. It trades about 0.05 of its potential returns per unit of risk. CytoMed Therapeutics Limited is currently generating about 0.06 per unit of risk. If you would invest  8.50  in Affiliated Resources Corp on December 21, 2024 and sell it today you would lose (1.50) from holding Affiliated Resources Corp or give up 17.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy98.36%
ValuesDaily Returns

Affiliated Resources Corp  vs.  CytoMed Therapeutics Limited

 Performance 
       Timeline  
Affiliated Resources Corp 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Affiliated Resources Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite inconsistent technical and fundamental indicators, Affiliated Resources disclosed solid returns over the last few months and may actually be approaching a breakup point.
CytoMed Therapeutics 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in CytoMed Therapeutics Limited are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, CytoMed Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Affiliated Resources and CytoMed Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Affiliated Resources and CytoMed Therapeutics

The main advantage of trading using opposite Affiliated Resources and CytoMed Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Affiliated Resources position performs unexpectedly, CytoMed Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytoMed Therapeutics will offset losses from the drop in CytoMed Therapeutics' long position.
The idea behind Affiliated Resources Corp and CytoMed Therapeutics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years